US FDA completes inspection at Cadila's Ahmedabad facility

Cadila Healthcare stated that United States Food and Drug Administration (FDA) has completed inspection at its manufacturing facility in Ahmedabad with no observations. "US FDA inspected the manufacturing facility of Alidac Pharmaceuticals, the company's wholly-owned subsidiary, located at SEZ, Ahmedabad from January 27, 2020 to February 4, 2020," the company said in a BSE filing. The site manufactures oncology injectables for the regulated markets. Cadila Healthcare Ltd is an Indian pharmaceutical company headquartered at Ahmedabad in Gujarat state of western India. It is a manufacturer of generic drugs.

Upload Company Info



Chemxpert Demo Video


Dataset Sample


Chemical Name

Synonyms

Molecular Formula

Molecular Weight


To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Innovator

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Market Status

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Indication

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Therapeutic Segment

To Access this information please pay by using "Pay & Download" button.

Pay & Download

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Thank you for your enquiry

Your product will be updated soon in our database


Submit Your Query



Select Any Option



Page loaded in 0.001057 seconds